Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Perspective Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 117 | 3 | 138 | +24 |
| Shares | 36.6M | 3.51M | 79.9M | +46.8M (+141.6%) |
| Value | $105.0M | $9.65M | $333.1M | +$237.8M (+249.3%) |
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (47)
Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (23)
Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Two Sigma Advisers, LP | 663,830 | $1.83M |
| Marshall Wace, LLP | 406,732 | $1.12M |
| Renaissance Technologies LLC | 352,493 | $969.4K |
| Sphera Funds Management Ltd. | 349,973 | $962.4K |
| Walleye Capital LLC | 328,667 | $903.8K |
| Point72 Asset Management, L.P. | 314,180 | $864.0K |
| Jane Street Group, LLC | 263,995 | $726.0K |
| XTX Topco Ltd | 82,476 | $226.8K |
| Graham Capital Management, L.P. | 80,193 | $220.5K |
| Schonfeld Strategic Advisors LLC | 62,370 | $171.5K |
| Massar Capital Management, LP | 52,000 | $143.0K |
| DAFNA Capital Management LLC | 50,000 | $137.5K |
| R Squared Ltd | 15,991 | $44.0K |
| Engineers Gate Manager LP | 12,562 | $34.5K |
| nVerses Capital, LLC | 11,420 | $31.4K |
| ProShare Advisors LLC | 10,889 | $29.9K |
| Raymond James Financial Inc | 10,730 | $29.5K |
| Aigen Investment Management, LP | 10,173 | $28.0K |
| Amalgamated Bank | 1,872 | $5.00K |
| Basecamp Wealth Advisors LLC | 202 | $556 |
| Northwestern Mutual Wealth Management Co | 36 | $99 |
| SRS Capital Advisors, Inc. | 15 | $41 |
| Root Financial Partners, LLC | 3 | $8 |
Not filed for Q1 2026 yet (3)
Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 3,490,658 | $9.60M |
| Sherbrooke Park Advisers LLC | 16,232 | $44.6K |
| Global Retirement Partners, LLC | 3,476 | $9.56K |